<DOC>
	<DOCNO>NCT00004898</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage cancer cell . Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Peripheral stem cell transplantation may allow doctor give high dos chemotherapy drug kill cancer cell . PURPOSE : Phase I/II trial study effectiveness radiation therapy chemotherapy plus peripheral stem cell transplantation treat patient high-grade lymphoma acute lymphoblastic leukemia .</brief_summary>
	<brief_title>Radiation Therapy Chemotherapy Plus Peripheral Stem Cell Transplantation Treating Patients With High-Grade Lymphoma Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : I . Determine toxicity intensive induction regimen comprise etoposide cyclophosphamide total body irradiation ( TBI ) patient high grade lymphoma acute lymphoblastic leukemia ( ALL ) . II . Determine maximum tolerate dose etoposide combine cyclophosphamide TBI patient . III . Determine response rate patient treat induction regimen . IV . Determine potential long term survival patient relapse lymphoblastic lymphoma chemotherapy responsiveness treat induction regimen . V. Determine efficacy induction regimen follow autologous peripheral blood stem cell transplantation ( APBSCT ) patient ALL complete remission . VI . Determine efficacy induction regimen follow APBSCT patient ALL relapse remission reinduction . OUTLINE : This dose escalation study etoposide . Patients undergo total body irradiation twice daily day -8 -5 . Patients receive etoposide IV 30 hour begin day -5 cyclophosphamide IV 1 hour day -3 ( begin 6 hour completion etoposide infusion ) day -2 . Peripheral blood stem cell reinfused day 0 . Patients receive filgrastim ( G-CSF ) subcutaneously daily begin day 0 continue blood count recover 2 day . Cohorts 5 patient receive escalate dos etoposide maximum tolerate dose ( MTD ) determine . The MTD define dose precede 3 5 patient experience dose limit toxicity . Patients follow every month 1 year every 6 month 2.5 year . PROJECTED ACCRUAL : A minimum 5 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven high grade lymphoma ( include small noncleaved ) lymph node biopsy OR acute lymphoblastic leukemia ( ALL ) bone marrow aspiration biopsy Lymphoblastic lymphoma : First remission allow elevated LDH stage IV disease Early relapse allow Must CT abdomen , pelvis , chest obtain within 46 week prior enrollment Measurable disease require First remission transplantation encourage poor prognostic indicator present diagnosis objective parameter measure long term disease free survival ALL : Patients inaspirable bone marrow aspirate smear eligible diagnosis confirm bone marrow core biopsy Any complete remission allow All patient relapse attempted reinduction remission Patients early relapse ( define great 20 % lymphoblasts bone marrow ) eligible bone marrow harvest remission ( le 5 % blast ) Must eligible total body irradiation Negative CSF cytology within 46 week enrollment No active CNS lymphoma leukemia A new classification scheme adult nonHodgkin 's lymphoma adopt PDQ . The terminology `` indolent '' `` aggressive '' lymphoma replace former terminology `` low '' , `` intermediate '' , `` high '' grade lymphoma . However , protocol us former terminology . PATIENT CHARACTERISTICS : Age : Physiologic age 65 autologous peripheral blood stem cell transplantation If age 55 , priority give find allogeneic donor Performance status : ECOG 0 1 Life expectancy : Not specify Hematopoietic : See Disease Characteristics Hepatic : Bilirubin great 2.0 mg/dL SGOT SGPT less 2 time normal Renal : Creatinine le 2.0 mg/dL Cardiovascular : Cardiac ejection fraction least 40 % MUGA scan clearance cardiologist No myocardial infarction within past 6 month No active angina pectoris Pulmonary : FEV1 DLCO least 50 % predict Other : No active serious psychiatric medical illness would preclude administration high dose chemotherapy HIV negative Not pregnant Negative pregnancy test PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy great 25 Gy craniospinal axis Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>stage I childhood lymphoblastic lymphoma</keyword>
	<keyword>stage II childhood lymphoblastic lymphoma</keyword>
	<keyword>stage III childhood lymphoblastic lymphoma</keyword>
	<keyword>stage IV childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>stage I adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage I adult lymphoblastic lymphoma</keyword>
	<keyword>stage I adult Burkitt lymphoma</keyword>
	<keyword>stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage II adult lymphoblastic lymphoma</keyword>
	<keyword>stage II adult Burkitt lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>stage I childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage I childhood large cell lymphoma</keyword>
	<keyword>stage II childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage II childhood large cell lymphoma</keyword>
	<keyword>stage III childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage III childhood large cell lymphoma</keyword>
	<keyword>stage IV childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage IV childhood large cell lymphoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
</DOC>